Pulmonary hypertension predicts adverse cardiac events after restrictive mitral annuloplasty for severe functional mitral regurgitation
Satoshi Kainuma(National Cerebral and Cardiovascular Center), Yoshiki Sawa(Osaka Police Hospital), Köichi Toda(The University of Osaka), Takashi Daimon(Hyogo Medical University), Masami Nishino(Saga University), Haruhiko Kondoh(Hyogo Medical University), Toshihiro Funatsu(Hyogo Medical University), Kazuhiro Taniguchi(Hyogo Medical University)
Cited by 40
Related Papers
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
|Nature Medicine|1997|589
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
|Circulation Journal|2020|363
Thoracic and cardiovascular surgeries in Japan during 2018
|General Thoracic and Cardiovascular Surgery|2020|123
JCS/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies
|Circulation Journal|2021|115